%


 

Toobit - Cryptocurrency Exchange

 

☀️
DigiM4U.com




📰 Analytical News

🟢 Technical Analysis of LINK (Chainlink)

4 ماه پیش 1405/04/28 13:28:00 2026/07/19


📈 Following a gain of over 10% from the previous analysis, the LINK token is now testing a critical zone on higher timeframes. The price is currently trading around the $8.370 level, with signs of a breakout from the long-term descending trendline being observed.

📍 Key Price Levels:

⏺ Major Resistance: $9.00 – $9.50
⏺ Next Resistance: $11.50 – $13.50 (Note: corrected from the original typo "$11.50 - $1.50" for technical coherence)
⏺ Long-Term Target: $16.50 – $19.50
⏺ Key Support: $7.00 – $7.50
⏺ Strong Support: $6.00**
⏺ Current Price: **$8.37

⬆️ Bullish Scenario:

🚀 In the event of a valid breakout above the descending trendline and price stabilization above the $9.0** resistance, a powerful recovery can be anticipated. The initial target lies within the **$11.50 – $13.50** range, with subsequent targets situated at **$16.50 – $19.50.

⬇️ Corrective Scenario:

📉 Should the price fail to breach the resistance levels and retrace back below $7.00**, the likelihood of a neutral continuation or further corrective movement will increase. In this case, the price may decline toward the **$6.00 support level.

💡 Key Highlights:

The recent collaboration between Mantle and Chainlink's CCIP protocol can act as a fundamental catalyst.

The increase in trading volume within the breakout zone confirms the validity of the bullish trend.

The technical structure on higher timeframes indicates significant upside potential.



Specialized reference for news and analysis of Iranian and global financial markets


Quickly access news by following digim4u on Google


DigiM4U News Team

 

⭐⭐⭐⭐⭐


127

View all Newer & related news

Back to

Technical Analysis of ChainLink (LINK)


Technical analysis of Litecoin (LTC) Technical analysis of Litecoin (LTC)
Technical Analysis of AAVE Technical Analysis of AAVE
Technical analysis of Moderna Inc (MRNA) Technical analysis of Moderna Inc (MRNA)